Health Condition 1: null- Patients with dengue fever
Conditions
Interventions
Intervention1: C.papaya capsule (Caripil)
: Caripil 1100 mg three times daily for 5 days, along with the standard regimen.
Control Intervention1: Placebo: The other group will receive placebo three t
Sponsors
Bangalore Baptist Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria a. Age 15-70 years and b. Dengue Ag/Ab OR both Ag, Ab positive c. Inpatients d. Platelet count less than 1,00,000 and e. Patients willing to participate in study and given informed consent
Exclusion criteria
Exclusion criteria: • Pregnant or lactating women • Patients with Dengue hemorrhagic fever grade III and IV, • Patients with platelet count less than 10000/micro liter • Patients with thrombocytopenia presenting with active bleeding • Patients who have received blood or blood products transfusion during the current illness or during past one week, • Patients with thrombocytopenia Purpura (ITP), Leukemia, Hemophilia or bleeding diathesis • Patients with history of papaya leaf extract consumption prior to admission. • Participation in another trial with another investigational drug within 1 month prior to informed consent. • The presence of any other condition that leads the investigator to conclude that the patient is inappropriate for inclusion in the clinical study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean platelet countTimepoint: Day 1, 2, 3,4 and 5 | — |
Secondary
| Measure | Time frame |
|---|---|
| Morbidity profile WBC count RBC countTimepoint: Days 1, 2, 3, 4 and 5 | — |
Countries
India
Contacts
Public ContactDr Carolin Elizabeth George
Bangalore Baptist Hospital
Outcome results
None listed